IP Library › Assignment 020010/0479
Patent Assignment
Reel/Frame 020010/0479

Assignment of Assignor's Interest

Recorded: 2007-10-25 Pages: 6
Assignor
CLARAGEN INC.
Executed: 2007-10-01
Assignee
CC10 SWEDEN AB
C/O LTB4 SWEDEN AB, GUSTAVIA OFFICE, KORNHAMNSTORG 53, P.O. BOX 2077, SE-103 12 STOCKHOLM, SWEDEN
Covered Properties (15)
Methods and Compositions for the Reduction of Neutrophil Influx and for the Treatment of Bronchpulmonary Dysplasia, Respiratory Distress Syndrome, Chronic Lung Disease, Pulmonary Fibrosis, Asthma and Chronic Obstructive Pulmonary Disease
Use of Recombinant Human Uteroglobin in Treatment of Inflammatory and Fibrotic Conditions
Patent: 6,255,281 →
Application: 08/864,357 →
Use of Recombinant Human Uterogobin in Treatment of Inflammtory and Fibrotic Conditions
Application: 09/087,210 →
Recombinant Human Uteroglobin in Treatment of Inflammatory and Fibrotic Conditions
Application: 09/120,264 →
Publication: US 2002/0160948
Methods and compositions for the treatment of fibrotic conditions & impaired lung functionn & to enhance lymphocyte production
Application: 09/549,926 →
Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
Application: 09/835,784 →
Publication: US 2003/0008816
Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
Application: 09/861,688 →
Publication: US 2002/0173460
Methods for the Production of Purified Recombinant Human Uteroglobin for the Treatment of Inflammatory and Fibrotic Conditions
Patent: 7,122,344 →
Application: 09/898,616 →
Publication: US 2003/0109429
Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
Application: 10/045,534 →
Publication: US 2002/0169108
Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
Application: 10/187,498 →
Publication: US 2003/0207795
Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
Application: 10/638,448 →
Publication: US 2005/0261180
Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
Application: 10/647,371 →
Publication: US 2004/0047857
Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
Application: 11/189,229 →
Publication: US 2006/0025348
Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
Application: 11/378,798 →
Publication: US 2006/0281681
Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
Application: 11/711,405 →
Publication: US 2008/0064633
Related Assignments (14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 26, 1997
From: PILON, APRILE L.
To: CLARAGEN, INC.
Reel/Frame 008728/0633 →
Assignment of Assignor's Interest Nov 20, 1997
From: MUKHERJEE, ANIL B.; ZHANG, ZHONGJIAN
To: HEALTH & HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH, UNITED STATES GOVERNMENT
Reel/Frame 008799/0943 →
Assignment of Assignor's Interest Aug 31, 1998
From: MUKHERJEE, ANIL B.; ZHANG, ZHONGJIAN; PILON, APRILE L.
To: NATIONAL INSTITUTES OF HEALTH; CLARAGEN, INC.
Reel/Frame 009440/0127 →
Assignment of Assignor's Interest Oct 5, 1998
From: MUCHERJEE, ANIL B.; ZHANG, ZHONGJIAN; PILON, APRILE L.
To: NATIONAL INSTITUTE OF HEALTH; CLARAGEN, INC.
Reel/Frame 009499/0145 →
Assignment of Assignor's Interest Jan 9, 2002
From: PILON, APRILE L.; WELCH, RICHARD; FARROW, JEFFREY; MELBY, JAMES
To: CLARAGEN, INC.
Reel/Frame 012445/0021 →
Assignment of Assignor's Interest Mar 1, 2002
From: PILON, APRILE L.; WELCH, RICHARD
To: CLARAGEN, INC.
Reel/Frame 012658/0543 →
Security Interest Jan 7, 2004
From: CLARAGEN, INC.
To: MARYLAND ANGELS COUNSEL, LLC ("MAC"); WOMENANGELS.NET, LLC
Reel/Frame 014861/0633 →
Security Agreement Jan 26, 2004
From: CLARAGEN, INC.
To: PILON, APRILE; MARYLAND HEALTH CARE PRODUCT DEVELOPMENT CORPORATION; GALLOWAY, WILLIAM R, AS TRUSTEE OF WILLIAM R. GALLOWAY TTEE U/A DTD 08/06/1998; WILLIAMS, RICHARD O., AS TRUSTEE OF RICHARD O. WILLIAMS REVOCABLE TRUST U/A/D FEBRUARY 28, 1996
Reel/Frame 015740/0858 →
Assignment of Assignor's Interest Sep 2, 2004
From: CLARAGEN, INC.
To: APRILE PILON; MARYLAND HEALTH CARE PRODUCT DEVELOPMENT CORPORATION; GALLOWAY, WILLIAM R. AS TRUSTEE OF WILLIAM R. GALLOWAY TTEE U/A DTD 08/061998; WILLIAMS, RICHARD O. AS TRUSTEE OF RICHARD O. WILLI
Reel/Frame 015748/0278 →
Corrective Security Interest to Delete U.S. Patent No. 6,599,031 and 6,436,619, Previously Recorded at Reel 14861 Frame 633. Apr 1, 2005
From: CLARAGEN, INC.
To: MARYLAND ANGELS COUNSEL, LLC ("MAC"); WOMENANGELS.NET, LLC
Reel/Frame 016429/0058 →
Release of Security Interest Feb 24, 2006
From: PILON-CLAYTON, APRILE L.; MARYLAND HEALTH CARE PRODUCT DEVELOPMENTS CORPORATION; GALLOWAY, WILLIAM R., AS TRUSTES OF WILLIAM GALLOWAY TIRE U/A DTD; WILLIAMS, RICHARD O. AS TRUSTEE OF RICHARD O. WILLIAMS TRUST U/A/D
To: CLARAGEN, INC.
Reel/Frame 017636/0951 →
Assignment of Assignor's Interest May 3, 2010
From: CC10 SWEDEN AB
To: CLARASSANCE, INC.
Reel/Frame 024320/0417 →
Assignment of Assignor's Interest May 3, 2010
From: CC10 SWEDEN AB
To: CLARASSANCE, INC.
Reel/Frame 024320/0397 →
Change of Name Apr 3, 2015
From: CLARASSANCE INC.
To: THERABRON THERAPEUTICS INC.
Reel/Frame 035365/0889 →